1. Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials. Issue 1 (4th November 2014) Authors: Benjo, Alexandre M; Garcia, Daniel C; Jenkins, J Stephen; Cardoso, Rhanderson M N; Molina, Taina P; El-Hayek, Georges E; Nadkarni, Girish N; Aziz, Emad F; Dinicolantonio, James J; Collins, Tyrone Journal: Open heart Issue: Volume 1:Issue 1(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗